Navigation Links
Ventana Medical Systems, Inc. Launches Virtuoso Software for Digital Pathology
Date:3/31/2011

TUCSON, Ariz., March 31, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc., a member of the Roche Group, announced today the availability of its next generation Virtuoso digital pathology application software.  

(Photo: http://photos.prnewswire.com/prnh/20110331/LA74593)

The new version of Virtuoso software expands pathologists' workflow capabilities with features that deliver additional gains in efficiency, collaboration, and productivity. Pathology labs worldwide will realize significant value and workflow improvements with the upgraded software enhancements including:

Pathologist workflow enhancements – ability to create a worklist that gives pathologists the flexibility to work on cases in their desired order; the option to include gross images in case reports; synchronized image viewing that is ideal for comparing serial sections on a case with different markers; and role-based portals to ensure that individual needs are met for each person in the pathology laboratory workflow.

Telepathology enhancements – the capability to conveniently share cases for review by other pathologists; a real-time collaboration feature enabling simultaneous peer reviews; and case review guidance for residents for educational purposes.

User Interface (UI) enhancements – context-sensitive toolbars for a faster and more intuitive viewer experience and an interactive UI that allows microscope-like panning and zooming on images.

Christopher Cestaro, Lifecycle Leader, Advanced Workflow, Ventana Medical Systems, Inc., commented, "Digital pathology is transforming the practice of pathology in ways that will significantly impact the delivery of healthcare in the future. Ventana digital pathology solutions fully leverage our strengths in high quality staining platforms, assays, and workflow solutions such as VANTAGE, to deliver a complete end-to-end solution for pathology laboratories. Our global leadership in the pathology market ensures that our customers continue to have access to the most innovative products and solutions."

The new features of the Virtuoso 5.0 software will improve the pathologist's ability to manage and share cases, and collaborate in real time. Virtuoso works with the VENTANA iScan Coreo Au scanner to deliver a comprehensive digital pathology solution from image acquisition to case management, report customization, and more.

Ventana test systems are for in vitro diagnostic use for specific clinical applications, and are intended for research use only for other applications.

About Ventana Medical Systems, Inc

Ventana Medical Systems, Inc. ("VMSI") develops, manufactures, and markets instrument/reagent systems that automate tissue preparation and slide staining in clinical histology and drug discovery laboratories worldwide. The Company's clinical systems are important tools used in the diagnosis and treatment of cancer and infectious diseases. VMSI's drug discovery systems are used to accelerate the discovery of new drug targets and evaluate the safety of new drug compounds. In addition, the Company offers premier workflow solutions designed to improve laboratory efficiency, providing safeguards to enhance the quality of healthcare. Ventana Medical Systems, Inc. is a wholly-owned member of the Roche Group. For more information on Ventana Medical Systems, Inc. visit www.ventana.com.

For further information, please contact:
Jacquie Bucher
Ventana Media Relations
520-877-7288  jacquie.bucher@ventana.roche.com


'/>"/>
SOURCE Ventana Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Endologix Announces First Clinical Implant of Ventana™ Stent Graft
2. CareGiver, Ventana Medical Systems, Inc. Remote Instrument Support, Has Expanded to Include the Ventana BenchMark ULTRA Automated Stainer
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Globus Medical Raises $110 Million in Series E Financing Round
7. Quark Pharmaceuticals Appoints New Chief Medical Officer
8. Boston University Biomedical Engineers Find Chink in Bacterias Armor
9. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
10. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , May 24, 2016 Celsion ... drug development company, today provided an update on ... escalating clinical trial combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  GEN-1 is an IL-12 DNA plasmid ...
(Date:5/24/2016)... May 24, 2016 Los ... terapia del mundo, introduce catéteres para la intervención ... OrbusNeich, una compañía global especializada en el suministro ... expandido su cartera incluyendo productos para tratar la ... Scoreflex™ PTA son los dispositivos de primera entrada ...
(Date:5/24/2016)... -- Dutch surgeons have launched a ground-breaking medical app ... treat patients on a global scale. Medical professionals from ... and the US have already signed up for the ... a totally secure environment. Education  "Imagine a ... with a surgeon at Harvard to treat a bomb victim via ...
Breaking Medicine Technology:
(Date:5/26/2016)... Hampshire (PRWEB) , ... May 26, 2016 , ... ... care products, has been honored with a 2016 When Work Works Award for its ... award, part of the national When Work Works project administered by the Families and ...
(Date:5/26/2016)... D.C. (PRWEB) , ... May 26, 2016 , ... On ... men and women who lost their lives in military battle for the country. ... cards in 2015 to provide more programs that empower independence for disabled military veterans, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the leading ... health and global clinical supply services, today announced two key appointments and the ... investment and strategic growth plans in the Asia Pacific region. , Howard Kim ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... of healthcare supply chain solutions, today announced the organization has earned its ISO ... international standards and is compliant with all rules and policies associated with ISO ...
(Date:5/26/2016)... ... May 26, 2016 , ... American orthopedic surgeon ... officer of Blue Horizon International (BHI), Brian Mehling, M.D., spoke at an International ... May 5-6, 2016 in Chicago, IL, USA. Dr. Mehling’s presentation was focused on ...
Breaking Medicine News(10 mins):